NL8301965A - Analogen van neurohypofysiaire hormonen met remmende effecten alsmede farmaceutische preparaten, die deze analogen bevatten. - Google Patents

Analogen van neurohypofysiaire hormonen met remmende effecten alsmede farmaceutische preparaten, die deze analogen bevatten. Download PDF

Info

Publication number
NL8301965A
NL8301965A NL8301965A NL8301965A NL8301965A NL 8301965 A NL8301965 A NL 8301965A NL 8301965 A NL8301965 A NL 8301965A NL 8301965 A NL8301965 A NL 8301965A NL 8301965 A NL8301965 A NL 8301965A
Authority
NL
Netherlands
Prior art keywords
water
dimethylformamide
ether
solution
added
Prior art date
Application number
NL8301965A
Other languages
English (en)
Dutch (nl)
Original Assignee
Ceskoslovenska Akademie Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CS824128A external-priority patent/CS229893B1/cs
Priority claimed from CS620682A external-priority patent/CS229896B1/cs
Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved
Publication of NL8301965A publication Critical patent/NL8301965A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8301965A 1982-06-03 1983-06-02 Analogen van neurohypofysiaire hormonen met remmende effecten alsmede farmaceutische preparaten, die deze analogen bevatten. NL8301965A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CS412882 1982-06-03
CS824128A CS229893B1 (cs) 1982-06-03 1982-06-03 Analogy oxytocinu a vasopresinu s inhibičními účinky a způsob jejich výroby
CS620682A CS229896B1 (cs) 1982-08-26 1982-08-26 Analogy vasopresinu a způsob jejich výroby
CS620682 1982-08-26

Publications (1)

Publication Number Publication Date
NL8301965A true NL8301965A (nl) 1984-01-02

Family

ID=25745957

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8301965A NL8301965A (nl) 1982-06-03 1983-06-02 Analogen van neurohypofysiaire hormonen met remmende effecten alsmede farmaceutische preparaten, die deze analogen bevatten.

Country Status (10)

Country Link
US (1) US4508645A (de)
BE (1) BE896943A (de)
CH (1) CH658061A5 (de)
DE (1) DE3320189A1 (de)
DK (1) DK233183A (de)
FR (1) FR2528036A1 (de)
GB (1) GB2122622B (de)
IT (1) IT1164260B (de)
NL (1) NL8301965A (de)
SE (1) SE8303091L (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711877A (en) * 1985-09-18 1987-12-08 Smithkline Beckman Corporation 6-pen-vasopressin compounds
WO1987002676A1 (en) * 1985-10-25 1987-05-07 Gibson-Stephens Neuropharmaceuticals, Inc. Conformationally constrained oxytocin antagonists with prolonged biological activities
US5055448A (en) * 1987-06-25 1991-10-08 Medical College Of Ohio Linear derivatives of arginine vasopressin antagonists
US5562812A (en) * 1995-04-03 1996-10-08 The Penn State Research Foundation Free flow electrophoresis device for biomolecule purification and separation in zero and one G

Also Published As

Publication number Publication date
DE3320189A1 (de) 1983-12-08
US4508645A (en) 1985-04-02
GB2122622A (en) 1984-01-18
BE896943A (fr) 1983-10-03
CH658061A5 (de) 1986-10-15
DK233183A (da) 1983-12-04
GB8315273D0 (en) 1983-07-06
IT1164260B (it) 1987-04-08
GB2122622B (en) 1986-01-08
SE8303091L (sv) 1983-12-04
IT8321431A0 (it) 1983-06-02
DK233183D0 (da) 1983-05-25
SE8303091D0 (sv) 1983-06-01
FR2528036A1 (fr) 1983-12-09

Similar Documents

Publication Publication Date Title
CA1185235A (en) Antagonists of the antidiuretic and/or vasopressor action of arginine vasopressin
EP0106404A2 (de) Peptide
Katayama et al. The phenacyl group as an efficient thiol protecting group in a peptide condensation reaction by the thioester method
NL8301965A (nl) Analogen van neurohypofysiaire hormonen met remmende effecten alsmede farmaceutische preparaten, die deze analogen bevatten.
FI64797C (fi) Foerfarande foer framstaellning av nya blodtrycknedsaettande peptider
Mayer et al. An alternative solid-phase approach to C1-oxytocin
Lebl et al. Oxytocin analogues with inhibitory properties, containing in position 2 a hydrophobic amino acid of D-configuration
Smith et al. Synthesis and some pharmacological properties of [3-. beta.-(2-thienyl)-L-alanine]-8-lysine-vasopressin
US4368150A (en) Method for protecting guanidino group and restoring the same
EP0078498B1 (de) Verfahren zum Schutz der Aminogruppe und Aufhebung derselben
Ten Kortenaar et al. Semisynthesis of horse heart cytochrome c analogues from two or three fragments.
Milne et al. Peptide synthesis via oxidation of N-acylamino acid phenylhydrazides. III. Dialanylinsulin and (bisphenylalanyl) insulin
BODANSZKY et al. SYNTHESIS OF 8‐L‐TRYPTOPHAN‐OXYTOCIN AND DETERMINATION OF ONE OF ITS CONFORMATIONAL PARAMETERS
Yasunobu et al. Amino-and carboxyl-terminal amino acid sequences of the Peptostreptococcus elsdenii and Clostridium pasteurianum flavodoxins
NL8301663A (nl) Analogen van neurohypofysiaire hormonen met remmende eigenschappen.
RU2063979C1 (ru) Пептиды последовательности окситоцина
Schafer et al. Amino-acids and peptides. Part XXXII. A simplified synthesis of bradykinin by use of the picolyl ester method
Krchňák et al. Effect of methylation of the hydroxyl group of tyrosine in [1-β-mercaptopropionic acid, 8-D-arginine] vasopressin on its biological effects
Hlaváček et al. The effect of non-coded amino acids on the degradation of oxytocin analogs with α-chymotrypsin
Žertová et al. Amino and deamino analogs of 8-D-homoarginin-vasopressin with modified tyrosine in position 2: synthesis and some biological properties
Žertová et al. The Analogs of 8-D-Homoarginin-vasopressin with O-Substituted Phenylalanine in Position 2: Synthesis and Some Biological Properties
Žertová et al. The analogs of 8-D-homoarginine-vasopressin with p-substituted phenylalanine in position 2; Synthesis and some biological properties
Jones Jr et al. N-Acetyl-[2-(O-methyl) tyrosine] arginine-vasopressin, an interesting antagonist of the vasopressor response to vasopressin
EP0001075B1 (de) Teilgeschützte Human-Insulin-A-Kette und Verfahren zu ihrer Herstellung
Žertová et al. The Analogs of [D-Har 8] Vasopressin with Di-and Trisubstituted Phenylalanine in Position 2; Synthesis and Some Biological Properties

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed